Thetford Mines, Quebec – TheNewswire - August 4, 2021 – KDA Group Inc. (TSXV:KDA) (“KDA” or the “Corporation”) and its wholly owned subsidiary, Groupe Technologique KDA Inc. (“Tech KDA”) are pleased to announce a partnership with CTRL Informatique Ltée (“CTRL”) and its technology platform Progident (“Progident”) for the integration of our KRx electronic prescribing platform for dentists (the “KRx”).
As previously disclosed in its press release dated April 7, 2021, Tech KDA announced the launch of the marketing and the commercialization for the Canadian market of its KRx. This pharmacological platform is specifically designed for dentists to facilitate and enhance their practice.
“We are pleased to be working with CTRL to commercialize the KRx. This partnership will allow Tech KDA’s KRx technology platform to be available to more than 1,700 dental professionals in Quebec,” said Sylvain Duvernay, Chief Executive Officer of KDA.
Progident has established itself as one of the most important dental management software in Quebec. With more than 1,700 dental professionals trusting it, Progident stands out for its great flexibility and its constant improvement to promote the computerization of dental practices and optimize user management. With more than 25 years of experience in the dental field, CTRL and its professional team meet the requirements of the industry and its Progident/Clinic and Progident/Finance softwares adapt to the budget, needs and reality of its users in order to offer a unique and efficient management environment.
“The integration of both systems, KRx and Progident, will allow dentists to have all the tools they need to optimize their time with their clients,” added Daniel Girard, President of CTRL.
The KRx main features are:
- A smart e-prescriber integrated directly into a dental software that dynamically analyzes the dentist prescription profile and displays the appropriate medication.
- Modules that electronically request the patient’s drugs list from their pharmacist and send their new prescriptions directly to their pharmacy.
- Decision trees and algorithms for selected drugs as well as immediate information on the primary use of a drug taken by a patient in order to reduce the medical risks.
- Access to RxVigilance, a Canadian drug database, to verify drug interactions and allergies and automatically calculate the pediatric dosage when necessary.
KDA Group is a leading technological innovations and specialized solutions provider in the pharmaceutical market. Today, it is a respected name for quality and expertise among the different stakeholders in the pharmaceutical and medical sector. Its management team is guided by a vision of continuing to lead the way in Quebec while extending operations across Canada and internationally. Additional information on the Corporation is available at www.kdagroup.ca and on SEDAR at www.sedar.com.
ABOUT CTRL
CTRL is a leading developer and provider of ERP management software for over 25 years. Recognized as a reference in the Quebec dental industry, its subsidiary Progident offers a complete dental management solution including a specialized EMR for dentistry as well as all the functionalities covering the day-to-day management of a dental clinic. Relying on a team of experienced specialists to offer a complete range of services to its dental clientele, CTRL is already present outside Quebec and intends to expand its Canadian coverage in the coming years. For more information, visit the company's website at www.ctrl.com.
- 30 -
CAUTION REGARDING FORWARD-LOOKING STATEMENTS
This press release from KDA Group contains forward-looking statements. Forward-looking statements are typically identified by the words assumption, goal, guidance, objective, outlook, strategy, target, and other similar expressions, or future or conditional verbs such as aim, anticipate, believe, predict, could, expect, intend, may, plan, seek, should, strive, and will. By their nature, forward-looking statements require us to make estimates and assumptions and express opinions based on current conditions and anticipated developments, as well as other factors that Management may deem appropriate under the circumstances. There is inherent uncertainty and significant risk in these estimates, assumptions, and opinions, particularly of a commercial, economic, and competitive nature, and they are therefore subject to change. KDA Group cannot guarantee that these estimates, assumptions, and opinions will prove to be accurate.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.
INFORMATION
Sylvain Duvernay
Chief Executive Officer
514 622-7370
Copyright (c) 2021 TheNewswire - All rights reserved.
